Good machine learning practice for medical device development: guiding principles
Overview
The U.S. Food and Drug Administration (FDA), Health Canada, and the United Kingdomās Medicines and Healthcare products Regulatory Agency (MHRA) have jointly identified 10 guiding principles that can inform the development of Good Machine Learning Practice (GMLP). These guiding principles will help promote safe, effective, and high-quality medical devices that use artificial intelligence and machine learning (AI/ML).
External Links
Key Information
Jurisdiction: North America - Canada, United States - Federal, UK
Date published: 27 Oct 2022